Leon… The Minister of Industry discusses the localization of pharmaceutical industries with international companies

9 hours ago

Less than a minute

Leon… The Minister of Industry discusses the localization of pharmaceutical industries with international companies

Hold and Mineral Resources Bandar bin Ibrahim Al-Khorayef, in the French city of Lyon, meeting with Thomas Triomphe, Executive Vice President and Head of the Vaccines Department at Sanofi International; To discuss ways to enhance industrial cooperation and explore joint opportunities to localize the vaccine and biopharmaceutical industry in the Kingdom.

During the meeting, the Minister watched a presentation on the company’s journey as a global pharmaceutical group, its strategic directions in manufacturing vaccines and biopharmaceuticals, the most prominent performance indicators, and its investments in research and development.

Vaccine Manufacturing

He visited Industrial facilities, production lines and quality laboratories, learning about the stages of manufacturing vaccines, starting with the development of active materials, through packaging processes according to the highest standards of safety and quality, all the way to strict inspection and control systems that ensure the efficiency and safety of products before they are put on the market.

In a related development, the Minister visited the headquarters of the Benta Group in the city of Lyon, accompanied by the Chairman of the Board of Directors and CEO of the Group, Bernard Tannoury. During the visit, he was briefed on an introductory presentation that reviewed the history of the vaccine. The group and its emergence in the French market, and its development in the field of pharmaceutical manufacturing.

These meetings and field tours come within the framework of a visit to official to the Republic of France, which aims to strengthen industrial partnerships, attract qualitative investments in the biopharmaceutical sector, and transfer knowledge and advanced technologies, in a way that supports the objectives of the national strategy for industry, and contributes to building national capabilities for the pharmaceutical and medical supplies industry that enhances the health security of the Kingdom.